Literature DB >> 22988116

Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling.

Driss El Moustaine1, Sébastien Granier, Etienne Doumazane, Pauline Scholler, Rita Rahmeh, Patrick Bron, Bernard Mouillac, Jean-Louis Banères, Philippe Rondard, Jean-Philippe Pin.   

Abstract

The eight metabotropic glutamate receptors (mGluRs) are key modulators of synaptic transmission and are considered promising targets for the treatment of various brain disorders. Whereas glutamate acts at a large extracellular domain, allosteric modulators have been identified that bind to the seven transmembrane domain (7TM) of these dimeric G-protein-coupled receptors (GPCRs). We show here that the dimeric organization of mGluRs is required for the modulation of active and inactive states of the 7TM by agonists, but is not necessary for G-protein activation. Monomeric mGlu2, either as an isolated 7TM or in full-length, purified and reconstituted into nanodiscs, couples to G proteins upon direct activation by a positive allosteric modulator. However, only a reconstituted full-length dimeric mGlu2 activates G protein upon glutamate binding, suggesting that dimerization is required for glutamate induced activation. These data show that, even for such well characterized GPCR dimers like mGluR2, a single 7TM is sufficient for G-protein coupling. Despite this observation, the necessity of dimeric architecture for signaling induced by the endogenous ligand glutamate confirms that the central core of signaling complex is dimeric.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22988116      PMCID: PMC3479612          DOI: 10.1073/pnas.1205838109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

Review 1.  Oligomerization of G-protein-coupled transmitter receptors.

Authors:  M Bouvier
Journal:  Nat Rev Neurosci       Date:  2001-04       Impact factor: 34.870

2.  A single subunit (GB2) is required for G-protein activation by the heterodimeric GABA(B) receptor.

Authors:  Béatrice Duthey; Sara Caudron; Julie Perroy; Bernhard Bettler; Laurent Fagni; Jean-Philippe Pin; Laurent Prézeau
Journal:  J Biol Chem       Date:  2001-11-15       Impact factor: 5.157

3.  Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+.

Authors:  Daisuke Tsuchiya; Naoki Kunishima; Narutoshi Kamiya; Hisato Jingami; Kosuke Morikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

4.  Allosteric interactions between GB1 and GB2 subunits are required for optimal GABA(B) receptor function.

Authors:  T Galvez; B Duthey; J Kniazeff; J Blahos; G Rovelli; B Bettler; L Prézeau; J P Pin
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

5.  Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2- trifluoroethylsulfonyl)pyrid-3-ylmethylamine.

Authors:  Michael P Johnson; Melvyn Baez; G Erik Jagdmann; Thomas C Britton; Thomas H Large; David O Callagaro; Joseph P Tizzano; James A Monn; Darryle D Schoepp
Journal:  J Med Chem       Date:  2003-07-17       Impact factor: 7.446

6.  Closure of the Venus flytrap module of mGlu8 receptor and the activation process: Insights from mutations converting antagonists into agonists.

Authors:  Anne-Sophie Bessis; Philippe Rondard; Florence Gaven; Isabelle Brabet; Nicolas Triballeau; Laurent Prezeau; Francine Acher; Jean-Philippe Pin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-31       Impact factor: 11.205

Review 7.  Metabotropic glutamate receptors as novel targets for anxiety and stress disorders.

Authors:  Chad J Swanson; Mark Bures; Michael P Johnson; Anni-Maija Linden; James A Monn; Darryle D Schoepp
Journal:  Nat Rev Drug Discov       Date:  2005-02       Impact factor: 84.694

8.  Sequential inter- and intrasubunit rearrangements during activation of dimeric metabotropic glutamate receptor 1.

Authors:  Veronika Hlavackova; Ulrike Zabel; Daniela Frankova; Julia Bätz; Carsten Hoffmann; Laurent Prezeau; Jean-Philippe Pin; Jaroslav Blahos; Martin J Lohse
Journal:  Sci Signal       Date:  2012-08-14       Impact factor: 8.192

9.  Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine.

Authors:  Pari Malherbe; Nicole Kratochwil; Marie-Thérèse Zenner; Jenny Piussi; Catherine Diener; Claudia Kratzeisen; Christophe Fischer; Richard H P Porter
Journal:  Mol Pharmacol       Date:  2003-10       Impact factor: 4.436

10.  Heptahelical domain of metabotropic glutamate receptor 5 behaves like rhodopsin-like receptors.

Authors:  Cyril Goudet; Florence Gaven; Julie Kniazeff; Claire Vol; Jiangfeng Liu; Martin Cohen-Gonsaud; Francine Acher; Laurent Prézeau; Jean Philippe Pin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

View more
  65 in total

1.  Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ-46281222.

Authors:  Maarten L J Doornbos; Laura Pérez-Benito; Gary Tresadern; Thea Mulder-Krieger; Ilse Biesmans; Andrés A Trabanco; Jose María Cid; Hilde Lavreysen; Adriaan P IJzerman; Laura H Heitman
Journal:  Br J Pharmacol       Date:  2016-01-13       Impact factor: 8.739

2.  Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia.

Authors:  José L Moreno; Patricia Miranda-Azpiazu; Aintzane García-Bea; Jason Younkin; Meng Cui; Alexey Kozlenkov; Ariel Ben-Ezra; Georgios Voloudakis; Amanda K Fakira; Lia Baki; Yongchao Ge; Anastasios Georgakopoulos; José A Morón; Graeme Milligan; Juan F López-Giménez; Nikolaos K Robakis; Diomedes E Logothetis; J Javier Meana; Javier González-Maeso
Journal:  Sci Signal       Date:  2016-01-12       Impact factor: 8.192

Review 3.  Emerging paradigms in GPCR allostery: implications for drug discovery.

Authors:  Denise Wootten; Arthur Christopoulos; Patrick M Sexton
Journal:  Nat Rev Drug Discov       Date:  2013-08       Impact factor: 84.694

4.  Conformational dynamics between transmembrane domains and allosteric modulation of a metabotropic glutamate receptor.

Authors:  Vanessa A Gutzeit; Jordana Thibado; Daniel Starer Stor; Zhou Zhou; Scott C Blanchard; Olaf S Andersen; Joshua Levitz
Journal:  Elife       Date:  2019-06-07       Impact factor: 8.140

5.  Major ligand-induced rearrangement of the heptahelical domain interface in a GPCR dimer.

Authors:  Li Xue; Xavier Rovira; Pauline Scholler; Han Zhao; Jianfeng Liu; Jean-Philippe Pin; Philippe Rondard
Journal:  Nat Chem Biol       Date:  2014-12-15       Impact factor: 15.040

6.  Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation.

Authors:  Karen J Gregory; P Jeffrey Conn
Journal:  Mol Pharmacol       Date:  2015-03-25       Impact factor: 4.436

7.  Extracellular calcium modulates actions of orthosteric and allosteric ligands on metabotropic glutamate receptor 1α.

Authors:  Jason Y Jiang; Mulpuri Nagaraju; Rebecca C Meyer; Li Zhang; Donald Hamelberg; Randy A Hall; Edward M Brown; P Jeffrey Conn; Jenny J Yang
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

8.  Agonist-dependent signaling by group I metabotropic glutamate receptors is regulated by association with lipid domains.

Authors:  Ranju Kumari; Catherine Castillo; Anna Francesconi
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

9.  The rhodopsin-transducin complex houses two distinct rhodopsin molecules.

Authors:  Beata Jastrzebska; Philippe Ringler; Krzysztof Palczewski; Andreas Engel
Journal:  J Struct Biol       Date:  2013-02-28       Impact factor: 2.867

Review 10.  Structural and Biophysical Mechanisms of Class C G Protein-Coupled Receptor Function.

Authors:  Amr Ellaithy; Javier Gonzalez-Maeso; Diomedes A Logothetis; Joshua Levitz
Journal:  Trends Biochem Sci       Date:  2020-08-26       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.